Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?JANSSEN, Harry L. A; SONNEVELD, Milan J; BRUNETTO, Maurizia R et al.Gut. 2012, Vol 61, Num 5, pp 641-645, issn 0017-5749, 5 p.Article

IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expressionLIU, Bi-Sheng; JANSSEN, Harry L. A; BOONSTRA, André et al.Blood. 2011, Vol 117, Num 8, pp 2385-2395, issn 0006-4971, 11 p.Article

Risk Factors for Infection During Treatment with Peginterferon alfa and Ribavirin for Chronic Hepatitis CROOMER, Robert; HANSEN, Bettina E; JANSSEN, Harry L. A et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 4, pp 1225-1231, issn 0270-9139, 7 p.Article

Experimental Models for Hepatitis C Viral InfectionBOONSTRA, Andre; VAN DER LAAN, Luc J. W; VANWOLLEGHEM, Thomas et al.Hepatology (Baltimore, Md.). 2009, Vol 50, Num 5, pp 1646-1655, issn 0270-9139, 10 p.Article

Retention of CD4⁺ CD25⁺ FoxP3⁺ Regulatory T Cells in the Liver after Therapy-Induced Hepatitis C Virus Eradication in HumansCLAASSEN, Mark A. A; DE KNEGT, Robert J; JANSSEN, Harry L. A et al.Journal of virology. 2011, Vol 85, Num 11, pp 5323-5330, issn 0022-538X, 8 p.Article

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expressionJANSSEN, Harry L. A; HIGUCHI, Hajime; ABDULKARIM, Ahmad et al.Journal of hepatology. 2003, Vol 39, Num 3, pp 414-420, issn 0168-8278, 7 p.Article

HBV DNA Suppression in HBeAg-Positive Chronic Hepatitis B Patients Treated With Peginterferon or PlaceboHANSEN, Bettina E; RIJCKBORST, Vincent; TER BORG, Martijn J et al.Journal of medical virology. 2011, Vol 83, Num 11, pp 1917-1923, issn 0146-6615, 7 p.Article

Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis CROOMER, Robert; HANSEN, Bettina E; JANSSEN, Harry L. A et al.Journal of hepatology. 2010, Vol 53, Num 3, pp 455-459, issn 0168-8278, 5 p.Article

A dynamic perspective of RNAi library developmentQIUWEI PAN; VAN DER LAAN, Luc J. W; JANSSEN, Harry L. A et al.Trends in biotechnology (Regular ed.). 2012, Vol 30, Num 4, pp 206-215, issn 0167-7799, 10 p.Article

Ribavirin Enhances Interferon-Stimulated Gene Transcription by Activation of the Interferon-Stimulated Response ElementQIUWEI PAN; TILANUS, Hugo W; JANSSEN, Harry L. A et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 4, pp 1400-1401, issn 0270-9139, 2 p.Article

Erythropoietin administration suppresses human monocyte function in vitro and during therapy-induced anemia in HCV patientsSPAAN, Michelle; GROOTHUISMINK, Zwier M. A; KONING, Ludi et al.Antiviral research. 2013, Vol 98, Num 3, pp 469-475, issn 0166-3542, 7 p.Article

Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi)QIUWEI PAN; RAMAKRISHNAIAH, Vedashree; HENRY, Scot et al.Gut. 2012, Vol 61, Num 9, pp 1330-1339, issn 0017-5749, 10 p.Article

Presence of Precore and Core Promoter Mutants Limits the Probability of Response to Peginterferon in Hepatitis B e Antigen-Positive Chronic Hepatitis BSONNEVELD, Milan J; RIJCKBORST, Vincent; ZEUZEM, Stefan et al.Hepatology (Baltimore, Md.). 2012, Vol 56, Num 1, pp 67-75, issn 0270-9139, 9 p.Article

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysisSMALBERG, Jasper H; ARENDS, Lidia R; VALLA, Dominique C et al.Blood. 2012, Vol 120, Num 25, pp 4921-4928, issn 0006-4971, 8 p.Article

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam studyKOEHLER, Edith M; SCHOUTEN, Jeoffrey N. L; HANSEN, Bettina E et al.Journal of hepatology. 2012, Vol 57, Num 6, pp 1305-1311, issn 0168-8278, 7 p.Article

The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosisSMALBERG, Jasper H; KOEHLER, Edith; JANSSEN, Harry L. A et al.Blood. 2011, Vol 117, Num 15, pp 3968-3973, issn 0006-4971, 6 p.Article

Etiology, Management, and Outcome of the Budd-Chiari SyndromeSARWA DARWISH MURAD; PLESSIER, Aurelie; HADENGUE, Antoine et al.Annals of internal medicine. 2009, Vol 151, Num 3, pp 167-175, issn 0003-4819, 9 p.Article

Paroxysmal nocturnal hemoglobinuria in Budd-Chiari Syndrome: Findings from a cohort studyHOEKSTRA, Jildou; LEEBEEK, Frank W. G; GARCIA-PAGAN, Juan-Carlos et al.Journal of hepatology. 2009, Vol 51, Num 4, pp 696-706, issn 0168-8278, 11 p.Article

Early changes of the portal tract on microcomputed tomography images in a newly-developed rat model for Budd-Chiari syndromeDARWISH MURAD, Sarwa; DOM, Veerle A. L; RITMAN, Erik L et al.Journal of gastroenterology and hepatology. 2008, Vol 23, Num 10, pp 1561-1566, issn 0815-9319, 6 p.Article

Flowcytometric quantitation of hepatitis B viral antigens in hepatocytes from regular and fine-needle biopsiesVAN DER LAAN, Luc J. W; TAIMR, Pavel; KOK, Alice et al.Journal of virological methods. 2007, Vol 142, Num 1-2, pp 189-197, issn 0166-0934, 9 p.Article

Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearanceJINLIN HOU; SCHILLING, Ralf; JANSSEN, Harry L. A et al.Journal of medical virology. 2007, Vol 79, Num 8, pp 1055-1063, issn 0146-6615, 9 p.Article

Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-α therapy for chronic hepatitis BSPRENGERS, Dave; STOOP, Jeroen N; BINDA, Rekha S et al.Antiviral therapy (London). 2007, Vol 12, Num 7, pp 1087-1096, issn 1359-6535, 10 p.Article

Aberrant composition of the dendritic cell population in hepatic lymph nodes of patients with hepatocellular carcinomaTANG, Thjon J; VUKOSAVLJEVIC, Dragica; JANSSEN, Harry L. A et al.Human pathology. 2006, Vol 37, Num 3, pp 332-338, issn 0046-8177, 7 p.Article

Circulating Vα24⁺Vβ11⁺ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patientsVAN DER VLIET, Hans J. J; MOLLING, Johan W; SCHEPER, Rik J et al.Clinical immunology (Orlando, Fla. Print). 2005, Vol 114, Num 2, pp 183-189, issn 1521-6616, 7 p.Article

Fibrinogen γ' and variation in fibrinogen gamma genes in the etiology of portal vein thrombosisSMALBERG, Jasper H; KOEHLER, Edith; VALLA, Dominique C et al.Thrombosis and haemostasis. 2013, Vol 109, Num 3, pp 558-560, issn 0340-6245, 3 p.Article